MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers18193097

Медицинская библиотека · Cancers · 2026

Longitudinal Assessment of EGFR and MET Transcriptional Activity Using Cell-Free Chromatin Immunoprecipitation in Two Patients with EGFR-Mutated Non-Small Cell Lung Cancer.

Pedersen Emma, Maansson Christoffer Trier, Meldgaard Peter, Sorensen Boe Sandahl

СтатьяПеревод пока не подготовлен

Аннотация

Background/

Objectives

MET amplification represents the most common bypass resistance mechanism to EGFR tyrosine kinase inhibitor (TKI) treatment in EGFR-mutated non-small cell lung cancer (NSCLC). Combination therapy with the EGFR-TKI, osimertinib, and the MET-TKI, crizotinib, has demonstrated clinical efficacy in overcoming this resistance. However, assessing MET transcriptional activity during treatment remains challenging.

Methods

Cell-free chromatin immunoprecipitation (cfChIP) targeting H3 lysine 36 trimethylation (H3K36me3) was employed to investigate the transcriptional activity of the EGFR and MET genes in serial liquid biopsies obtained from two patients with EGFR-mutated NSCLC. Droplet digital PCR (ddPCR) was used to quantify circulating tumor DNA (ctDNA) and cfChIP enrichment levels.

Results

In PT1, H3K36me3 mEGFR and MET cfChIP enrichment increased during disease progression, with MET enrichment increasing further following the initiation of crizotinib/osimertinib combination therapy, during which the patient experienced a partial response. In PT2, MET amplification was detected in a liquid biopsy, but MET cfChIP enrichment remained low throughout the treatment course, and the patient did not respond to crizotinib.

Conclusions

This two-patient feasibility study illustrates the potential of cfChIP-ddPCR for the longitudinal assessment of EGFR and MET transcriptional activity in liquid biopsies. These observations warrant further investigation of cfChIP as an approach for monitoring transcriptional activity during osimertinib/crizotinib treatment.

Для цитирования: Pedersen Emma, Maansson Christoffer Trier, Meldgaard Peter, Sorensen Boe Sandahl. Longitudinal Assessment of EGFR and MET Transcriptional Activity Using Cell-Free Chromatin Immunoprecipitation in Two Patients with EGFR-Mutated Non-Small Cell Lung Cancer.. Cancers. 2026. DOI: 10.3390/cancers18193097.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.